Recordati and Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced recently the signing of a European licensing agreement for the development and commercialization of NX-1207, Nymox’s Phase III investigational drug currently in clinical development in the U.S. for the treatment of benign prostatic hyperplasia (BPH).
Under the terms of the agreement, Recordati receives exclusive rights to develop and subsequently market and sell NX-1207 in Europe including Russia and the CIS, the Middle East, the Maghreb area of North Africa and South Africa (i.e. a total of 81 countries). The licensing agreement covers the use of NX-1207 for the treatment of BPH as the initial indication for development and commercialization. Recordati will make an upfront payment to Nymox of EURO 10 million (approximately $13 million); approval and sales milestones payments; and tiered supply and royalty payments of a minimum of 26% to increase progressively up to 40% of total net sales in the case specific contractual conditions are achieved.
RBC Capital Markets, LLC served as financial advisor and provided assistance to Nymox with respect to this transaction.
Nymox is a biotechnology company engaged in the research and development of therapeutics and diagnostics, with a particular emphasis on products targeted for the unmet needs of the aging population.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
GreenHouse Holdings, Inc. (OTCQB:GRHU) reported that it has been engaged to utilize Southern California Edison�s (SCE) Automated Demand Response (Auto-DR) program in Gulfstream Aerospace Corporation�s Long Beach, CA facility. GreenHouse is a qualified service provider of SCE�s Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies and complete processing of all incentives.
Furthermore, GreenHouse Holdings reported the results of operations for the third quarter of Fiscal Year 2010 and is providing a shareholder update. Signed Letter of Intent to acquire Control Engineering, Inc (CEI). Headquartered in Costa Mesa, California and serving clients globally, CEI provides turnkey automation and control solutions including engineering, installation and integration services.
Recently, Emissary Capital Group LLC Reaffirmed $7 price objective on GreenHouse Holdings. To read the complete report, click here: http://pennyomega.com/img/GRHU_update_101810%20%282%29.pdf
Emissary Capital Group, LLC. is a New York City-based company that provides strategic consulting and research services to public emerging growth companies. The firm also provides a diversified array of services to small and medium sized private companies, generally defined as those with annual revenues under $200 million, in order to assist them to become publicly traded companies in the U.S
GreenHouse Holdings, Inc. is a leading provider of energy efficiency solutions and sustainable infrastructure products. GreenHouse Holdings designs, engineers and installs disparate products and technologies with visible return on investment, enabling our clients to reduce their energy costs.
No comments:
Post a Comment